BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10942060)

  • 21. Regulation of interferon responses in medulloblastoma cells by interferon regulatory factor-1 and -2.
    Park KC; Shimizu K; Hayakawa T; Tanaka N
    Br J Cancer; 1998 Jun; 77(12):2081-7. PubMed ID: 9649118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic stimulation of MHC class I and IRF-1 gene expression by IFN-gamma and TNF-alpha in oligodendrocytes.
    Agresti C; Bernardo A; Del Russo N; Marziali G; Battistini A; Aloisi F; Levi G; Coccia EM
    Eur J Neurosci; 1998 Sep; 10(9):2975-83. PubMed ID: 9758167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of IFN-beta element by IRF-1 requires a posttranslational event in addition to IRF-1 synthesis.
    Watanabe N; Sakakibara J; Hovanessian AG; Taniguchi T; Fujita T
    Nucleic Acids Res; 1991 Aug; 19(16):4421-8. PubMed ID: 1886766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7.
    Sancéau J; Hiscott J; Delattre O; Wietzerbin J
    Oncogene; 2000 Jul; 19(30):3372-83. PubMed ID: 10918594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon regulatory factor-1 and -2 expression in human melanoma specimens.
    Lowney JK; Boucher LD; Swanson PE; Doherty GM
    Ann Surg Oncol; 1999 Sep; 6(6):604-8. PubMed ID: 10493631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppressed induction of 2-5AS in cells with HTLV-I is not associated with the fluctuation of IFN-receptor, IFN-regulatory factors (IRF-1 and IRF-2) or STAT-1 alpha.
    Yokosawa N; Indoh T; Kubota T; Yashiki T; Fujii N
    Microbiol Immunol; 1997; 41(1):63-6. PubMed ID: 9087969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct activation of murine interferon-alpha promoter region by IRF-1/ISFG-2 and virus infection.
    Au WC; Raj NB; Pine R; Pitha PM
    Nucleic Acids Res; 1992 Jun; 20(11):2877-84. PubMed ID: 1614874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptional regulation of the 230-kDa bullous pemphigoid antigen gene expression by interferon regulatory factor 1 and interferon regulatory factor 2 in normal human epidermal keratinocytes.
    Odanagi M; Kikuchi Y; Yamazaki T; Kaneko T; Nakano H; Tamai K; Uitto J; Hanada K
    Exp Dermatol; 2004 Dec; 13(12):773-9. PubMed ID: 15560761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways.
    Fujita T; Reis LF; Watanabe N; Kimura Y; Taniguchi T; Vilcek J
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9936-40. PubMed ID: 2557635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of the interferon regulatory factors, IRF-1 and IRF-2, in LPS-induced cyclooxygenase-2 (COX-2) expression in vivo and in vitro.
    Zhang S; Thomas K; Blanco JC; Salkowski CA; Vogel SN
    J Endotoxin Res; 2002; 8(5):379-88. PubMed ID: 12537697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon alpha induction of Stat1 and Stat2 and their prognostic significance in carcinoid tumors.
    Zhou Y; Wang S; Gobl A; Oberg K
    Oncology; 2001; 60(4):330-8. PubMed ID: 11408801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defective binding of IRFs to the initiator element of interleukin-1beta-converting enzyme (ICE) promoter in an interferon-resistant Daudi subline.
    Iwase S; Furukawa Y; Kikuchi J; Saito S; Nakamura M; Nakayama R; Horiguchi-Yamada J; Yamada H
    FEBS Lett; 1999 May; 450(3):263-7. PubMed ID: 10359086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcription factor IRF-2 exerts its oncogenic phenotype through the DNA binding/transcription repression domain.
    Nguyen H; Mustafa A; Hiscott J; Lin R
    Oncogene; 1995 Aug; 11(3):537-44. PubMed ID: 7630638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of IFN type-I receptor and IFN regulatory factor expression relating to induction of 2', 5'-oligoadenylate synthetase in cells persistently infected with the mumps virus.
    Fujii N; Yokosawa N; Ishida S; Shirakawa S; Kubota T; Indoh T; Fujinaga K; Yashiki T
    Microbiol Immunol; 1996; 40(10):777-81. PubMed ID: 8981353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localization of interferon regulatory factor-1 (IRF-1) in nonpregnant human endometrium: expression of IRF-1 is up-regulated by prolactin during the secretory phase of the menstrual cycle.
    Jabbour HN; Critchley HO; Yu-Lee LY; Boddy SC
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4260-5. PubMed ID: 10566682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family.
    Bovolenta C; Driggers PH; Marks MS; Medin JA; Politis AD; Vogel SN; Levy DE; Sakaguchi K; Appella E; Coligan JE
    Proc Natl Acad Sci U S A; 1994 May; 91(11):5046-50. PubMed ID: 8197182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxic response of ovarian cancer cell lines to IFN-gamma is associated with sustained induction of IRF-1 and p21 mRNA.
    Burke F; Smith PD; Crompton MR; Upton C; Balkwill FR
    Br J Cancer; 1999 Jun; 80(8):1236-44. PubMed ID: 10376977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiproliferative effects of retinoic acid/interferon in cervical carcinoma cell lines: cooperative growth suppression of IRF-1 and p53.
    Um SJ; Kim EJ; Hwang ES; Kim SJ; Namkoong SE; Park JS
    Int J Cancer; 2000 Feb; 85(3):416-23. PubMed ID: 10652435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-occupancy of the interferon regulatory element of the class II transactivator (CIITA) type IV promoter by interferon regulatory factors 1 and 2.
    Xi H; Eason DD; Ghosh D; Dovhey S; Wright KL; Blanck G
    Oncogene; 1999 Oct; 18(43):5889-903. PubMed ID: 10557076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IFN-stimulated gene 15 is synergistically activated through interactions between the myelocyte/lymphocyte-specific transcription factors, PU.1, IFN regulatory factor-8/IFN consensus sequence binding protein, and IFN regulatory factor-4: characterization of a new subtype of IFN-stimulated response element.
    Meraro D; Gleit-Kielmanowicz M; Hauser H; Levi BZ
    J Immunol; 2002 Jun; 168(12):6224-31. PubMed ID: 12055236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.